|
|
|
|
Science Sparks @ ACTREC
|
 12thMay 2025 |
Vol. No. 14 ; Issue No.682 |
|
|
Publications
|
|
1. Shaikh N, Pandey M, Manna S, Gawde J, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB (2025). Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy. Oral Oncology. 165: 107346.
2. Choudhary B, Chaudhary N, Khan B, Vijan A, Mandal D, Pilankar L, Gawand S, Uttankar P, Sharma M, Shivashankar A, Doloi R, Joshi N, Das M, Dalal SN (2025). LCN2 promotes focal adhesion formation and invasion by stimulating Src activation. Journal of Cell Science.
|
|
|
|
|
Interesting Reads
|
|
Jiang M, Zhang K, Wei G, Qi F, Yu D, Ma J, Zhang X, Chen L, Xie Y, Yu Z, Chen J, Chen D (2025). HDAC4 super-enhancer drives CEBPB-mediated TWIST2 transcription to promote chemoresistance in LUAD. Cancer Letters.
|
|
|
Video of the Week
|
|
| Recent Advances in PET Technology |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2004, Azacitidine, an inhibitor of DNA methylation and a pioneering epigenetic therapy, became the first drug to gain US Food and Drug Administration (FDA) approval for the treatment of myelodysplastic syndrome.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Childhood brain tumors develop early in highly specialized nerve cells.
|
|
EurekAlert, 07/05/2025
|
|
The study shows that the particularly aggressive medulloblastomas of subgroups three and four probably develop between the first trimester of pregnancy and the end of the first year of life. The origin of the tumor development are the precursor cells of highly specialized nerve cells, the so-called unipolar brush cells of the cerebellum, which also develop between the first trimester...
|
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
